Overview
Reuven Schore is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Schore is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), and Osteosarcoma.
His clinical research consists of co-authoring 35 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Schore has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Tobey Macdonald is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Macdonald is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant.
Johns Hopkins University
Eric Raabe is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Raabe is rated as an Elite provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Rhabdoid Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Pediatric Low-Grade Glioma (pLGG).
Brian Rood is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Rood is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Schore isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- LeukemiaDr. Schore isDistinguished. Learn about Leukemia.
- Advanced
- Juvenile Myelomonocytic Leukemia (JMML)
- Experienced
- Acute Erythroid Leukemia (AEL)Dr. Schore isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Childhood Acute Myeloid LeukemiaDr. Schore isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Ewing SarcomaDr. Schore isExperienced. Learn about Ewing Sarcoma.
- Febrile NeutropeniaDr. Schore isExperienced. Learn about Febrile Neutropenia.
- Malignant Peripheral Nerve Sheath TumorDr. Schore isExperienced. Learn about Malignant Peripheral Nerve Sheath Tumor.
- MedulloblastomaDr. Schore isExperienced. Learn about Medulloblastoma.